Jaguar Health (JAGX) Free Cash Flow (2014 - 2026)

Jaguar Health (JAGX) has 13 years of Free Cash Flow data on file, last reported at $8.9 million in Q1 2026.

• On a quarterly basis, Free Cash Flow rose 221.23% year-over-year to $8.9 million in Q1 2026; TTM through Mar 2026 was -$6.4 million, a 78.82% increase from a year earlier, with the FY2025 full-year figure at -$22.5 million, up 23.43% from the prior year.
• Free Cash Flow for Q1 2026 stood at $8.9 million, up from -$4.3 million in the prior quarter.
• Over the last five years, Free Cash Flow for JAGX reached as high as $8.9 million in Q1 2026 and fell as low as -$11.6 million in Q2 2022.
• Historically, Free Cash Flow has averaged -$6.4 million across 5 years, with a median of -$7.3 million in 2025.
• Across the five-year window, Free Cash Flow tumbled 45.9% in 2023 and soared 221.23% in 2026, its largest moves.
• Year by year, Free Cash Flow stood at -$5.1 million in 2022, then plunged by 45.9% to -$7.4 million in 2023, then slipped by 0.85% to -$7.5 million in 2024, then surged by 43.27% to -$4.3 million in 2025, then soared by 308.1% to $8.9 million in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were $8.9 million in Q1 2026, -$4.3 million in Q4 2025, and -$4.8 million in Q3 2025.